Allogeneic T-Cells Expressing an Anti-CD19 Chimeric Antigen Receptor Cause Remissions of B-Cell Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation without Causing Graft-Versus-Host Disease
Year: 2015
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Jennifer N Brudno, Robert Somerville, Victoria Shi, Jeremy J. Rose, David C. Halverson, Daniel H. Fowler, Dennis D. Hickstein, Juan C. Gea-Banacloche, Steven Z. Pavletic, Andre Goy, Tangying L Lu, Steven Feldman, Alex Iwamoto, Roger Kurlander, Irina Maric, Brenna Hansen, Jennifer S. Wilder, Bazetta Blacklock-Shuver, Frances T. Hakim, Steven A. Rosenberg, Ronald E. Gress, James N. Kochenderfer
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2554942862